Stanford Medicine X-Health Care and Emerging Technologies
斯坦福大学医学 X-医疗保健和新兴技术
基本信息
- 批准号:8431532
- 负责人:
- 金额:$ 9.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-01 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Stanford Medicine X is a conference dedicated to innovation and the application of emerging technology to improve medicine and health care. One central aspect of innovation at the core of the mission of our conference is to re-engineer the entire system of research and care of patients with chronic disease. Where our current system might represent an upside-down pyramid where knowledge and innovation is expected to spring up from the top of a rigid hierarchy, with highly specialized academics and practitioners
at the top, and eventually trickle down to patients, our hypothesis is that it makes sense for knowledge to derive from the real experts: patients and their caregivers. Therefore, we believe that there can be a new approach to an academic conference that places the patient at the center of discussion and that will unite all healthcare stakeholders- patients, healthcare professionals, technologists, and researchers-together to help solve health care issues from a patient centered perspective. There is no other academic conference dedicated to exploring the intersection of healthcare and emerging technologies specifically from a patient-centered perspective. This proposal seeks funding through the AHRQ R13 grant mechanism to support the conference meetings in 2012, 2013, and 2014. The sole PI for the conference outlined in this proposal is Larry Chu, MD, MS, head of the Anesthesia Informatics and Media (AIM) Lab at Stanford, Associate Professor of Anesthesia, and Organizing Chair for the successful Medicine 2.0 Summit and 4th World Congress at Stanford. Stanford Medicine X will convene for three days annually in September at the Li Ka Shing Center for Learning on the Stanford campus. The objectives of the Medicine X are: 1. To advance understanding of how innovative technologies have the potential to improve patient care and ease the burden of disease from a patient-centered perspective, including tools to empower patients to be involved in their own care. 2. To provide a forum concentrated on uniting stakeholders in health care for opportunities to network and collaborate in innovative, interdisciplinary research and/or technology solutions. 3. To provide education in major areas relevant to emerging technology and their application to clinical medicine. 4. To integrate the patient voice and patient-centered design into the use of emerging technologies to improve health care. 5. To identify those measureable outcomes that are most meaningful to patients and to bring researchers closer to understanding how to incorporate patient-centered design and outcomes into their research. The meeting will be one of the major venues for researchers in the realm of emerging technology and medicine to present and publish their work and to network with a diverse audience of health care providers, patients, technologists, and academicians. Conference proceedings will be published in the official open access conference journals: Journal of Visualized Experiments (JoVE) and Public Library of Science (PLoS ONE). The location of Medicine X at the Stanford School of Medicine allows attendees the access to a breadth of experts and an unmatched number of technologists and health start-ups based in the Silicon Valley.
PUBLIC HEALTH RELEVANCE: The Stanford Medicine X conference will be a forum for discussion of emerging technologies and their impact on the future of medicine and health care, from a patient-centered perspective. There is no other meeting dedicated to exploring the intersection of healthcare and emerging technologies specifically from a patient- centered perspective. Medicine X is focused on bringing health care stakeholders together in an academic conference that shares a stage between researchers, leaders in innovation, and patients.
描述(由申请人提供):斯坦福医学X是致力于创新和新兴技术来改善医学和医疗保健的会议。创新的一个核心方面是我们会议任务的核心,是重新设计整个慢性疾病患者的研究和护理体系。我们当前的系统可能代表了颠倒的金字塔,其中预计知识和创新将从僵化的层次结构的顶部出现,并具有高度专业的学者和从业者
在顶部,最终向患者流传,我们的假设是,从真实的专家中获得知识是有意义的:患者及其护理人员。因此,我们认为,可以有一种新的学术会议方法,将患者置于讨论的中心,并将所有医疗保健利益相关者 - 患者,医疗保健专业人员,技术人员和研究人员结合在一起,以帮助解决医疗保健问题。患者以焦点为中心。从以患者为中心的角度来看,没有其他学术会议致力于探索医疗保健和新兴技术的交集。该提案通过AHRQ R13赠款机制寻求资金,以支持2012年,2013年和2014年的会议会议。该提案中概述的会议的唯一PI是MD,MS MS,MS MS的负责人,麻醉信息和媒体负责人(AIM AIM )在斯坦福大学(Stanford)的实验室,麻醉副教授,并在斯坦福大学(Stanford)组织成功的医学2.0峰会和第四届世界大会。斯坦福医学X将在9月在斯坦福校园学习的李卡·夏(Li Ka Shing)学习中心每年召开三天。药物X的目标是:1。从以患者为中心的角度来了解创新技术如何改善患者护理并减轻疾病负担的潜力,包括使患者能够参与自身护理的工具。 2。提供一个论坛,专注于将利益相关者团结起来,以寻求卫生保健的机会,以与创新,跨学科研究和/或技术解决方案进行联网和合作。 3。在与新兴技术有关的主要领域提供教育及其在临床医学上的应用。 4。将患者的语音和以患者为中心的设计整合到新兴技术以改善医疗保健中。 5。确定那些对患者最有意义的可测量结果,并使研究人员更加了解如何将以患者为中心的设计和结果纳入其研究中。这次会议将是新兴技术和医学领域研究人员的主要场所之一,以展示和发布其作品,并与多样化的医疗保健提供者,患者,技术人员和院士建立联系。会议会议记录将发表在官方的开放访问会议期刊上:可视化实验杂志(JOVE)和公共科学图书馆(PLOS One)。医学X在斯坦福大学医学院的位置允许与会者进入硅谷的专家和无与伦比的技术人员和健康初创企业。
公共卫生相关性:从以患者为中心的角度来看,斯坦福大学X会议将是讨论新兴技术及其对医学和医疗保健未来的影响的论坛。没有其他专门从事以患者为中心的角度探索医疗保健和新兴技术的交集的会议。 Medicine X专注于在一个学术会议上将医疗保健利益相关者聚集在一起,该会议分享了研究人员,创新领导者和患者之间的阶段。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LAWRENCE F CHU其他文献
LAWRENCE F CHU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LAWRENCE F CHU', 18)}}的其他基金
Understanding the Effects of Chronic Opioids Therapy in Humans
了解慢性阿片类药物治疗对人类的影响
- 批准号:
8636421 - 财政年份:2013
- 资助金额:
$ 9.87万 - 项目类别:
Understanding the Effects of Chronic Opioids Therapy in Humans
了解慢性阿片类药物治疗对人类的影响
- 批准号:
8509170 - 财政年份:2013
- 资助金额:
$ 9.87万 - 项目类别:
Stanford Medicine X-Health Care and Emerging Technologies
斯坦福大学医学 X-医疗保健和新兴技术
- 批准号:
8530189 - 财政年份:2012
- 资助金额:
$ 9.87万 - 项目类别:
Stanford Medicine X-Health Care and Emerging Technologies
斯坦福大学医学 X-医疗保健和新兴技术
- 批准号:
8691496 - 财政年份:2012
- 资助金额:
$ 9.87万 - 项目类别:
5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Phy
5HT3 拮抗剂治疗阿片类药物戒断并预防 Physical 进展
- 批准号:
8240984 - 财政年份:2011
- 资助金额:
$ 9.87万 - 项目类别:
5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Phy
5HT3 拮抗剂治疗阿片类药物戒断并预防 Physical 进展
- 批准号:
8451522 - 财政年份:2011
- 资助金额:
$ 9.87万 - 项目类别:
5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Phy
5HT3 拮抗剂治疗阿片类药物戒断并预防 Physical 进展
- 批准号:
8041122 - 财政年份:2011
- 资助金额:
$ 9.87万 - 项目类别:
Opiate-Induced Tolerance & Hyperalgesia in Pain Patients
阿片类药物引起的耐受性
- 批准号:
7118009 - 财政年份:2004
- 资助金额:
$ 9.87万 - 项目类别:
Opiate-Induced Tolerance & Hyperalgesia in Pain Patients
阿片类药物引起的耐受性
- 批准号:
6807970 - 财政年份:2004
- 资助金额:
$ 9.87万 - 项目类别:
Opiate-Induced Tolerance & Hyperalgesia in Pain Patients
阿片类药物引起的耐受性
- 批准号:
6918649 - 财政年份:2004
- 资助金额:
$ 9.87万 - 项目类别:
相似国自然基金
国家药品带量采购政策实施效果评价及影响因素分析研究
- 批准号:72304006
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于医保战略性购买的国家药品价格谈判政策因果效应、长效机制及优化策略研究
- 批准号:72374167
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
天然水体中药品和个人护理品间接光降解产物预测模型的构建和应用
- 批准号:42307496
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
药品网上零售即时配送的时空协同优化方法研究
- 批准号:72371044
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
复杂网络视角下互联网药品销售安全风险识别、度量及协同治理研究
- 批准号:72304280
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Pacific-Stanford PRIMED Program: Training the next generation of clinical oral health researchers
太平洋-斯坦福 PRIMED 计划:培训下一代临床口腔健康研究人员
- 批准号:
10755235 - 财政年份:2023
- 资助金额:
$ 9.87万 - 项目类别:
Multidisciplinary K12 Urologic Research at Stanford (KUReS) Career Development Program
斯坦福大学多学科 K12 泌尿学研究 (KUReS) 职业发展计划
- 批准号:
10731681 - 财政年份:2023
- 资助金额:
$ 9.87万 - 项目类别:
Center for Dissemination and Implementation At Stanford (C-DIAS)
斯坦福大学传播与实施中心 (C-DIAS)
- 批准号:
10493956 - 财政年份:2022
- 资助金额:
$ 9.87万 - 项目类别: